An Overview of the GI Fellowship Interview: Part II-Tips for Selection Committees and Interviewers.

Authors:
Advani R; Bollipo S; Charabaty A; Duong N; Bilal M and 2 more

Journal:
Dig Dis Sci

Publication Year: 2022

DOI:
10.1007/s10620-022-07409-8

PMCID:
PMC8817657

PMID:
35122593

Journal Information

Full Title: Dig Dis Sci

Abbreviation: Dig Dis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration Conflict of interestRashmi Advani has no conflicts of interest to disclose. Nikki Duong has no conflicts of interest to disclose. Mohammad Bilal has no conflicts of interest to disclose. Keith Siau has no conflicts of interest to disclose. Steven Bollipo has no conflicts of interest to disclose. Aline Charabaty is on the Advisory board/consulting for Abbvie, Janssen, Takeda, Pfizer, BMS. She is the Creator of @MondayNightIBD and Co-Creator of Scrubs & Heels, LLC. Samir C. Grover has received research grants and personal fees from AbbVie and Ferring Pharmaceuticals, personal fees from Takeda, education grants from Janssen, and has equity in Volo Healthcare. Conflict of interest Rashmi Advani has no conflicts of interest to disclose. Nikki Duong has no conflicts of interest to disclose. Mohammad Bilal has no conflicts of interest to disclose. Keith Siau has no conflicts of interest to disclose. Steven Bollipo has no conflicts of interest to disclose. Aline Charabaty is on the Advisory board/consulting for Abbvie, Janssen, Takeda, Pfizer, BMS. She is the Creator of @MondayNightIBD and Co-Creator of Scrubs & Heels, LLC. Samir C. Grover has received research grants and personal fees from AbbVie and Ferring Pharmaceuticals, personal fees from Takeda, education grants from Janssen, and has equity in Volo Healthcare."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025